PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
3219332-8	1988	The binding and transfer vs chain length profiles were quite similar for C(16)Pyr(x)PC and C(16)Pyr(x)PI species, suggesting that the sn-2 acyl chains of PI and PC share a common binding site in PI-TP.	neotetrazolium	198-200	solute carrier family 38 member 5	Bos taurus	134-138
3179276-4	1988	The sugar puckering of Tp- is dominated by the 2E conformer, but in -pT it is in 4E; except for the conformer around C5"-O5" bond, the 6-4 isomer is very similar to those of cis-syn and trans-syn conformation.	neotetrazolium	23-25	synemin	Homo sapiens	192-195
3179276-9	1988	While the trans-syn photodimer has two structural isomers, only one [C6(of Tp-)-R] was produced by the UV irradiation and studied.	neotetrazolium	75-77	synemin	Homo sapiens	16-19
6798728-1	1981	The paper deals with the influence of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2.2-dichloroethane (o,p"-DDD, chloditane) on NADPH-dependent reduction of cytochrome c, ferricyanide, 2,6-dichlorophenolindophenol and neotetrazolium; 156 and 312 mumol o,p"-DDD was added to the dog adrenal mitochondrial and microsomal suspension.	neotetrazolium	211-225	cytochrome c, somatic	Canis lupus familiaris	150-162
3179276-4	1988	The sugar puckering of Tp- is dominated by the 2E conformer, but in -pT it is in 4E; except for the conformer around C5"-O5" bond, the 6-4 isomer is very similar to those of cis-syn and trans-syn conformation.	neotetrazolium	23-25	synemin	Homo sapiens	178-181
6186695-1	1983	When non-malignant cells were reacted for glucose-6-phosphate dehydrogenase activity, with neotetrazolium chloride as the indicator of the activity, oxygen competed with the neotetrazolium and nullified the reaction.	neotetrazolium	91-114	glucose-6-phosphate dehydrogenase	Homo sapiens	42-75
6186695-1	1983	When non-malignant cells were reacted for glucose-6-phosphate dehydrogenase activity, with neotetrazolium chloride as the indicator of the activity, oxygen competed with the neotetrazolium and nullified the reaction.	neotetrazolium	91-105	glucose-6-phosphate dehydrogenase	Homo sapiens	42-75
3111786-5	1987	The integrated insulin response to a 75g OGTT in the TP group increased by 48.3% at 6 months compared with an increase of 23.4% for the same period in the IUD group.	neotetrazolium	53-55	insulin	Homo sapiens	15-22
29552824-1	2018	To explore the effects and molecular mechanisms of triptolide(TP)on improving podocyte epithelial-mesenchymal transition(EMT)induced by high dose of D-glucose(HG), the immortalized podocytes of mice in vitro were divided into the normal group(N), the high dose of D-glucose group(HG), the low dose of TP group(L-TP), the high dose of TP group(H-TP)and the mannitol group(MNT), and treated by the different measures respectively.	neotetrazolium	62-64	IL2 inducible T cell kinase	Mus musculus	121-124
32176847-5	2020	TP-008 has excellent cellular potency and strongly abrogates phosphorylation of the substrate SMAD2 (mothers against decapentaplegic homologue 2).	neotetrazolium	0-2	SMAD family member 2	Homo sapiens	94-99
30903412-12	2020	The TP group had a lower lung wet to dry weight ratio, lung injury score, and MPO, TNF-, and IL-8 concentrations than the MO group (P < 0.05).	neotetrazolium	4-6	myeloperoxidase	Sus scrofa	78-81
30903412-12	2020	The TP group had a lower lung wet to dry weight ratio, lung injury score, and MPO, TNF-, and IL-8 concentrations than the MO group (P < 0.05).	neotetrazolium	4-6	tumor necrosis factor	Sus scrofa	83-86
30903412-12	2020	The TP group had a lower lung wet to dry weight ratio, lung injury score, and MPO, TNF-, and IL-8 concentrations than the MO group (P < 0.05).	neotetrazolium	4-6	C-X-C motif chemokine ligand 8	Sus scrofa	93-97
30641088-4	2019	The molecular markers of cardiac hypertrophy along with androgen receptor (AR) and PKCdelta, were increased in the Maternal-TP group.	neotetrazolium	124-126	androgen receptor	Rattus norvegicus	56-73
30641088-4	2019	The molecular markers of cardiac hypertrophy along with androgen receptor (AR) and PKCdelta, were increased in the Maternal-TP group.	neotetrazolium	124-126	androgen receptor	Rattus norvegicus	75-77
30306335-11	2019	However, only NaF-gel2 and NaF-TP induced remineralization.	neotetrazolium	31-33	C-X-C motif chemokine ligand 8	Homo sapiens	27-30
31424649-11	2019	Moreover, the positive expression rate of P-gp was also different among the 3 groups, and it was increased in the TP group, while it was decreased in the RH and rAd-p53 + TP group (p<0.05).	neotetrazolium	114-116	phosphoglycolate phosphatase	Homo sapiens	42-46
31424649-11	2019	Moreover, the positive expression rate of P-gp was also different among the 3 groups, and it was increased in the TP group, while it was decreased in the RH and rAd-p53 + TP group (p<0.05).	neotetrazolium	171-173	phosphoglycolate phosphatase	Homo sapiens	42-46
30277822-6	2019	Further deletion of E prostanoid receptor type 3 (EP3-/-) removed the PGF2alpha-evoked contraction that remained in some TP-/- arteries and added to the effect of TP-/- on the elevation in blood pressure evoked by the prostanoid under in vivo conditions.	neotetrazolium	121-123	prostaglandin E receptor 3 (subtype EP3)	Mus musculus	20-57
29565447-21	2018	Univariate and multivariate analyses revealed that age, CA125, interstitial IL-6 expression and cytoreduction satisfaction were closely related to the sensitivity of the TP (docetaxel plus cisplatin or carbopatin) regimen in ovarian cancer (P<0.05).	neotetrazolium	170-172	mucin 16, cell surface associated	Homo sapiens	56-61
29565447-21	2018	Univariate and multivariate analyses revealed that age, CA125, interstitial IL-6 expression and cytoreduction satisfaction were closely related to the sensitivity of the TP (docetaxel plus cisplatin or carbopatin) regimen in ovarian cancer (P<0.05).	neotetrazolium	170-172	interleukin 6	Homo sapiens	76-80
29516720-3	2018	In this work, a novel two-photon fluorescent probe TP-HNO was designed and synthesized based on 6-hydroxyl-quinonline-2-benzothiazole derivatives through introducing 2-(diphenylphosphino)benzoate as the ideal HNO recognition unit, which demonstrated the merits of outstanding selectivity, excellent sensitivity (DL 0.19 muM) and rapid response (20 min).	neotetrazolium	51-53	latexin	Homo sapiens	320-323
27349952-7	2017	Despite higher RBV-TP levels, individuals with variant ITPA phenotypes had less anemia.	neotetrazolium	19-21	inosine triphosphatase	Homo sapiens	55-59
29234377-1	2017	To investigate the potential role of nuclear factor erythroid 2-related factor 2 (Nrf2) in licorice ethanol extract (LEE) against triptolide- (TP-) induced hepatotoxicity, HepG2 cells were exposed to LEE (30, 60, and 90 mg L-1) for 12 h and then treated with TP (50 nM) for 24 h. Besides, an acute liver injury model was established in ICR mice by a single dose of TP (1.0 mg kg-1, i.p.).	neotetrazolium	143-145	NFE2 like bZIP transcription factor 2	Homo sapiens	82-86
29234377-6	2017	Furthermore, the decreased level of Nrf2 in the TP-treated group was observed.	neotetrazolium	48-50	NFE2 like bZIP transcription factor 2	Homo sapiens	36-40
28681218-1	2017	The aim of this study is to evaluate the outcome and safety of the multidisciplinary strategy using cisplatin plus dose-dense paclitaxel (dose-dense TP) before and after radical hysterectomy (RH) for stage IB2, IIA2, or IIB patients with cervical cancer.	neotetrazolium	149-151	mitogen-activated protein kinase 8 interacting protein 2	Homo sapiens	206-209
28414431-1	2017	Orange Tp*WSCl2 has been synthesized from the reactions of Tp*WOCl2 with boron sulfide in refluxing toluene or Tp*WS2Cl with PPh3 in dichloromethane at room temperature.	neotetrazolium	7-9	caveolin 1	Homo sapiens	125-129
27776874-2	2017	Pilot scale study showed that when the influent COD, TP and TSS were 73.0, 1.40 and 24.6mgL-1, the effluent COD, TP and TSS were 48.9, 0.32, 7.78mgL-1 for System-A with the ozone and Fe2+ dosage of 25mgL-1 and 0.08mmolL-1, and 60.2, 1.16, 6.44mgL-1 for System-B with the ozone dosage of 25mgL-1.	neotetrazolium	53-55	LLGL scribble cell polarity complex component 1	Homo sapiens	88-93
27831827-4	2016	We identified 3 conserved Sp/Tp residues that are located in the N-terminal, most conserved part, of SPAT-1/Bora.	neotetrazolium	29-31	Protein aurora borealis	Caenorhabditis elegans	101-107
27349952-9	2017	This finding of higher RBV-TP concentrations in RBCs in ITPA variants was unexpected given that ITPA activity-deficient individuals have a reduced likelihood of RBV-induced anemia.	neotetrazolium	27-29	inosine triphosphatase	Homo sapiens	56-60
27349952-9	2017	This finding of higher RBV-TP concentrations in RBCs in ITPA variants was unexpected given that ITPA activity-deficient individuals have a reduced likelihood of RBV-induced anemia.	neotetrazolium	27-29	inosine triphosphatase	Homo sapiens	96-100
27195913-4	2016	The present study reported that phosphorylated caspase-8 at tyrosine 380 (p-Casp8) was characterized as a biomarker of chemoresistance to TP regimen (cisplatin and paclitaxel) in patients with resectable lung adenocarcinoma with significantly poorer 5-year disease-free survival (DFS) and overall survival (OS).	neotetrazolium	138-140	caspase 8	Homo sapiens	47-72
29964668-6	2016	In the dry season, average concentrations of TN and TP were 4.25 mg L-1 and 0.11 mg L-1, respectively, compared to the corresponding values of 3.15 mg L-1 and 0.09 mg L-1 in wet season.	neotetrazolium	52-54	immunoglobulin kappa variable 1-16	Homo sapiens	68-80
29964668-6	2016	In the dry season, average concentrations of TN and TP were 4.25 mg L-1 and 0.11 mg L-1, respectively, compared to the corresponding values of 3.15 mg L-1 and 0.09 mg L-1 in wet season.	neotetrazolium	52-54	immunoglobulin kappa variable 1-16	Homo sapiens	68-71
29964668-6	2016	In the dry season, average concentrations of TN and TP were 4.25 mg L-1 and 0.11 mg L-1, respectively, compared to the corresponding values of 3.15 mg L-1 and 0.09 mg L-1 in wet season.	neotetrazolium	52-54	immunoglobulin kappa variable 1-16	Homo sapiens	84-87
29964668-6	2016	In the dry season, average concentrations of TN and TP were 4.25 mg L-1 and 0.11 mg L-1, respectively, compared to the corresponding values of 3.15 mg L-1 and 0.09 mg L-1 in wet season.	neotetrazolium	52-54	immunoglobulin kappa variable 1-16	Homo sapiens	84-87
27334096-2	2016	Exposure of Tp(Ph,Me)NiCH2Ph (1a) and Tp(Ph,Me)NiCH2Si(CH3)3 (1b) to CS2 resulted in formation of the insertion products Tp(Ph,Me)Ni(eta(2)-CS2)CH2Ph (2a) and Tp(Ph,Me)Ni(eta(2)-CS2)CH2Si(CH3)3 (2b) in moderate yields.	neotetrazolium	12-14	chorionic somatomammotropin hormone 2	Homo sapiens	69-72
27334096-2	2016	Exposure of Tp(Ph,Me)NiCH2Ph (1a) and Tp(Ph,Me)NiCH2Si(CH3)3 (1b) to CS2 resulted in formation of the insertion products Tp(Ph,Me)Ni(eta(2)-CS2)CH2Ph (2a) and Tp(Ph,Me)Ni(eta(2)-CS2)CH2Si(CH3)3 (2b) in moderate yields.	neotetrazolium	12-14	chorionic somatomammotropin hormone 2	Homo sapiens	140-143
27334096-2	2016	Exposure of Tp(Ph,Me)NiCH2Ph (1a) and Tp(Ph,Me)NiCH2Si(CH3)3 (1b) to CS2 resulted in formation of the insertion products Tp(Ph,Me)Ni(eta(2)-CS2)CH2Ph (2a) and Tp(Ph,Me)Ni(eta(2)-CS2)CH2Si(CH3)3 (2b) in moderate yields.	neotetrazolium	12-14	chorionic somatomammotropin hormone 2	Homo sapiens	140-143
27195913-4	2016	The present study reported that phosphorylated caspase-8 at tyrosine 380 (p-Casp8) was characterized as a biomarker of chemoresistance to TP regimen (cisplatin and paclitaxel) in patients with resectable lung adenocarcinoma with significantly poorer 5-year disease-free survival (DFS) and overall survival (OS).	neotetrazolium	138-140	caspase 8	Homo sapiens	76-81
26589827-9	2016	The activities of glutathione peroxidase (GPx) and superoxide dismutase (SOD) were higher and the concentration of malondialdehyde (MDA) was lower in the broilers fed 5 % TP than those of the broilers fed other diets at 28 days of age.	neotetrazolium	171-173	glutathione peroxidase	Solanum lycopersicum	18-40
29964716-7	2016	During the period of monitoring, the pCO2 and pCH4 in surface water were significantly correlated with pH, DO, chlorophyll a, TP, surface water temperature and water level.	neotetrazolium	126-128	tRNA splicing endonuclease subunit 54	Homo sapiens	46-50
26589827-9	2016	The activities of glutathione peroxidase (GPx) and superoxide dismutase (SOD) were higher and the concentration of malondialdehyde (MDA) was lower in the broilers fed 5 % TP than those of the broilers fed other diets at 28 days of age.	neotetrazolium	171-173	glutathione peroxidase	Solanum lycopersicum	42-45
26387142-8	2015	In the combined TH/TP/HP treatment group, in multivariate analysis, higher expression of PD1, MHC2, and STAT1 were linked with pCRB, and higher PDL1, MHC1, or IF-I to lower pCRB.	neotetrazolium	19-21	programmed cell death 1	Homo sapiens	89-92
29733157-7	2016	When TN exceeded 1.298 mg L-1 or TP exceeded 0.065 mg L-1(i.e. positive response threshold), even tolerant taxa would be influenced and the whole assemblage would be changed significantly.	neotetrazolium	33-35	immunoglobulin kappa variable 1-16	Homo sapiens	54-57
26556866-5	2015	Elevated levels of two different CRNDE transcripts were a negative prognostic factor; they increased the risk of death and recurrence in the group of patients treated with TP, but not PC (DNA-damaging agents only).	neotetrazolium	172-174	colorectal neoplasia differentially expressed	Homo sapiens	33-38
26387142-8	2015	In the combined TH/TP/HP treatment group, in multivariate analysis, higher expression of PD1, MHC2, and STAT1 were linked with pCRB, and higher PDL1, MHC1, or IF-I to lower pCRB.	neotetrazolium	19-21	signal transducer and activator of transcription 1	Homo sapiens	104-109
26387142-8	2015	In the combined TH/TP/HP treatment group, in multivariate analysis, higher expression of PD1, MHC2, and STAT1 were linked with pCRB, and higher PDL1, MHC1, or IF-I to lower pCRB.	neotetrazolium	19-21	CD274 molecule	Homo sapiens	144-148
26809410-1	2015	Tapentadol(TP)is a new strong opioid analgesicthat has both m-opioid receptor(MOR)effects and norepinephrine reuptake inhibitor(NRI)effects.	neotetrazolium	11-13	opioid receptor mu 1	Homo sapiens	78-81
26248960-14	2015	Immunoblot analysis showed a significant decrease in phosphorylated Akt levels after treatment with T or T + P in nonbasal cells but not in basal cells.	neotetrazolium	105-110	AKT serine/threonine kinase 1	Homo sapiens	68-71
26344782-1	2015	Dinitrogen complexes of the type Tp(R,R)Cr-N2-CrTp(R,R) are not the most labile precursors for Cr(i) chemistry, as they are sterically protected from obligatory associative ligand substitution.	neotetrazolium	33-35	calreticulin	Homo sapiens	46-50
25988234-3	2015	The maximum NO conversion over the Cr-HP(3)/TP catalyst reached 71.4% at 280  C. The catalysts were characterized by powder X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), temperature-programmed reduction of H2 (H2-TPR), temperature-programmed desorption (TPD) and diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) techniques.	neotetrazolium	44-46	translocated promoter region, nuclear basket protein	Homo sapiens	320-323
26095956-1	2015	The stable cationic iridacyclopentenylidene [Tp(Me2)Ir(=CHC(Me)=C(Me)CH2(NCMe)]PF6 (A; Tp(Me2)=hydrotris(3,5-dimethylpyrazolyl)borate) has been obtained by alpha-hydride abstraction from the iridacyclopent-2-ene [Tp(Me2)Ir(CH2C(Me)=C(Me)CH2)(NCMe)].	neotetrazolium	45-47	sperm associated antigen 17	Homo sapiens	79-82
26095956-1	2015	The stable cationic iridacyclopentenylidene [Tp(Me2)Ir(=CHC(Me)=C(Me)CH2(NCMe)]PF6 (A; Tp(Me2)=hydrotris(3,5-dimethylpyrazolyl)borate) has been obtained by alpha-hydride abstraction from the iridacyclopent-2-ene [Tp(Me2)Ir(CH2C(Me)=C(Me)CH2)(NCMe)].	neotetrazolium	87-89	sperm associated antigen 17	Homo sapiens	79-82
26095956-1	2015	The stable cationic iridacyclopentenylidene [Tp(Me2)Ir(=CHC(Me)=C(Me)CH2(NCMe)]PF6 (A; Tp(Me2)=hydrotris(3,5-dimethylpyrazolyl)borate) has been obtained by alpha-hydride abstraction from the iridacyclopent-2-ene [Tp(Me2)Ir(CH2C(Me)=C(Me)CH2)(NCMe)].	neotetrazolium	87-89	sperm associated antigen 17	Homo sapiens	79-82
26095956-3	2015	The coordination of an extra molecule of acetonitrile to the iridium center initiates the reversible isomerization of the chelating carbon chain of A to the monodentate butadienyl ligand of complex [Tp(Me2)Ir(CH=C(Me)C(Me)=CH2)(NCMe)2]PF6, which is capable to engage in a water-promoted C-C coupling with the MeCN co-ligands.	neotetrazolium	199-201	sperm associated antigen 17	Homo sapiens	235-238
26148543-4	2015	The availability of the acidic alpha-proton of the acac ligand was tested by the treatment of complex with Br2 and Cu(NO3)2 rendering the substitution complexes [Tp(3-Br,Me2)Ir(3-Br-acac)Br] () and [Tp(Me2)Ir(3-NO2-acac)(C2H5)] () in good yields.	neotetrazolium	162-164	malic enzyme 2	Homo sapiens	170-173
26148543-4	2015	The availability of the acidic alpha-proton of the acac ligand was tested by the treatment of complex with Br2 and Cu(NO3)2 rendering the substitution complexes [Tp(3-Br,Me2)Ir(3-Br-acac)Br] () and [Tp(Me2)Ir(3-NO2-acac)(C2H5)] () in good yields.	neotetrazolium	162-164	malic enzyme 2	Homo sapiens	202-205
25242657-3	2014	The introduction of TeO(2) as a third glass former to the glass network causes the structural transformation from TeO(3) (tp) to TeO(4) (tbp) which contributes to the changes in conductivity.	neotetrazolium	122-125	TATA-box binding protein	Homo sapiens	137-140
25816284-11	2015	Overexpression of miR-206 increased reactive oxygen species (ROS) levels in vitro and in vivo, whereas miR-206 silencing attenuated irradiation- or A-TP-induced ROS.	neotetrazolium	150-152	microRNA 206	Canis lupus familiaris	103-110
25538206-10	2015	E and TP/CDP were associated with a higher risk of recurrent hypoglycemia episodes (unadjusted hazard ratio: 6.18 ((95% CI: 1.54-24.8); P=0.010) for E vs DP and 9.51 ((95% CI: 1.85-48.8); P=0.007) for TP/CDP vs DP.	neotetrazolium	6-8	cut like homeobox 1	Homo sapiens	204-207
25538206-10	2015	E and TP/CDP were associated with a higher risk of recurrent hypoglycemia episodes (unadjusted hazard ratio: 6.18 ((95% CI: 1.54-24.8); P=0.010) for E vs DP and 9.51 ((95% CI: 1.85-48.8); P=0.007) for TP/CDP vs DP.	neotetrazolium	201-203	cut like homeobox 1	Homo sapiens	9-12
25341014-3	2014	In contrast to [(Tp(Me,Me))Ni-SAr] analogues that adopt a sawhorse conformation, the ortho-disubstituted complexes show enhanced trigonal and Ni-S-Ar bending, reflecting the size of the 3-pyrazole substituents.	neotetrazolium	17-19	sarcosine dehydrogenase	Homo sapiens	30-33
24864245-7	2014	These results highlight the importance of the hydrophobic C-6 linker in THP polymers in forming compact nanostructures with pDNA, which might lead to efficient uptake and internalization of the complexes; however, the projected TP polymers offer an advantage of their rapid and economical one-step synthesis.	neotetrazolium	228-230	complement C6	Homo sapiens	58-61
22200727-9	2012	Of note, both the positive expression of NF-kappaBp65 (P<0.01 vs. the T and P groups) and p-ERK1/2 (P<0.05 vs. the P group) was lowest in the TP group.	neotetrazolium	148-150	mitogen activated protein kinase 3	Rattus norvegicus	95-101
24173213-8	2014	Cellular PPIase Pin1 binds specifically to phosphoserine- or phosphothreonine-proline (pS/T-P) motifs in target proteins.	neotetrazolium	90-93	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	Homo sapiens	9-20
24048894-10	2013	T+P also blocked the induction of IL-6 to prevent the Th17 response, attenuated the expression of the costimulatory molecule CD86 on myeloid dendritic cells (DCs), and reduced the number of DCs carrying OVA in the lung and mediastinal lymph nodes.	neotetrazolium	0-3	interleukin 6	Mus musculus	34-38
24048894-10	2013	T+P also blocked the induction of IL-6 to prevent the Th17 response, attenuated the expression of the costimulatory molecule CD86 on myeloid dendritic cells (DCs), and reduced the number of DCs carrying OVA in the lung and mediastinal lymph nodes.	neotetrazolium	0-3	CD86 antigen	Mus musculus	125-129
23504554-5	2013	The gene-gene interaction of miR-34b/c rs4938723 and TP-53 Arg72-Pro showed that the combined genotypes of rs4938723CT/CC and TP-53CG/CC increased the risk of NPC (rs4938723CT/CC + TP-53CG/CC vs. rs4938723 TT+TP-53 CG/CC: OR=1.58, 95 % CI 1.04-2.42, p=0.03).	neotetrazolium	53-55	microRNA 34b	Homo sapiens	29-36
23504554-5	2013	The gene-gene interaction of miR-34b/c rs4938723 and TP-53 Arg72-Pro showed that the combined genotypes of rs4938723CT/CC and TP-53CG/CC increased the risk of NPC (rs4938723CT/CC + TP-53CG/CC vs. rs4938723 TT+TP-53 CG/CC: OR=1.58, 95 % CI 1.04-2.42, p=0.03).	neotetrazolium	53-55	tumor protein p53	Homo sapiens	126-131
23401098-0	2013	Reactivity studies of iridium pyridylidenes [Tp(Me2)Ir(C(6)H(5))(2)(C(CH)(3)C(R)NH] (R=H, Me, Ph).	neotetrazolium	45-47	malic enzyme 2	Homo sapiens	48-51
22958397-6	2012	The cells transfected with TPE (0.5:1:160) exhibited the highest enhancement of tyrosinase enzyme activity of 11.82-, 7.67-, 5.07-, and 6.29-folds of control, P, PE, and TP (0.5:1) and melanin production of 13.03-, 8.46-, 5.36-, and 6.58-folds of control, P, PE, and TP (0.5:1), respectively.	neotetrazolium	27-29	tyrosinase	Homo sapiens	80-90
22958397-6	2012	The cells transfected with TPE (0.5:1:160) exhibited the highest enhancement of tyrosinase enzyme activity of 11.82-, 7.67-, 5.07-, and 6.29-folds of control, P, PE, and TP (0.5:1) and melanin production of 13.03-, 8.46-, 5.36-, and 6.58-folds of control, P, PE, and TP (0.5:1), respectively.	neotetrazolium	170-172	tyrosinase	Homo sapiens	80-90
26588967-2	2012	This work presents a detailed analysis of the physical origin of the zero-field splittings (ZFSs) in a series of high-spin (S = 1) nickel(II) scorpionate complexes Tp*NiX (Tp* = hydrotris(3,5-dimethylpyrazole)borate, X = Cl, Br, I) using quantum chemical approaches.	neotetrazolium	164-166	BCL2 interacting protein 3 like	Homo sapiens	167-170
24366160-0	2014	A DFT study on structures, frontier molecular orbitals and UV-vis spectra of RuX(PPh3)(NHCPh2)L (X=Tp and Cp; L=Cl and N3).	neotetrazolium	99-101	protein phosphatase 4 catalytic subunit	Homo sapiens	81-85
24366160-1	2014	Geometry optimization for RuX(PPh3)(NHCPh2)(L) (X=hydridotris(pyrazolyl)borate (Tp) and cyclopentadiene (Cp); L=Cl and N3) are investigated by using density functional theory (DFT) with DZVP2/DZVP all-electron mixed basis sets and compared with available experimental values, and the calculated structures are in very good agreement with experimental data.	neotetrazolium	80-82	protein phosphatase 4 catalytic subunit	Homo sapiens	30-34
22029414-0	2011	Synthesis, structures, and reactivity of yttrium alkyl and alkynyl complexes with mixed Tp(Me2)/Cp ligands.	neotetrazolium	88-90	malic enzyme 2	Homo sapiens	91-94
22029414-1	2011	The structurally characterized Tp(Me2)-supported rare earth metal monoalkyl complex (Tp(Me2))CpYCH(2)Ph(THF) (1) was synthesized via the salt-metathesis reaction of (Tp(Me2))CpYCl(THF) with KCH(2)Ph in THF at room temperature.	neotetrazolium	31-33	malic enzyme 2	Homo sapiens	34-37
22029414-1	2011	The structurally characterized Tp(Me2)-supported rare earth metal monoalkyl complex (Tp(Me2))CpYCH(2)Ph(THF) (1) was synthesized via the salt-metathesis reaction of (Tp(Me2))CpYCl(THF) with KCH(2)Ph in THF at room temperature.	neotetrazolium	31-33	malic enzyme 2	Homo sapiens	88-91
22029414-1	2011	The structurally characterized Tp(Me2)-supported rare earth metal monoalkyl complex (Tp(Me2))CpYCH(2)Ph(THF) (1) was synthesized via the salt-metathesis reaction of (Tp(Me2))CpYCl(THF) with KCH(2)Ph in THF at room temperature.	neotetrazolium	31-33	malic enzyme 2	Homo sapiens	88-91
20668692-2	2010	Human cdc25C is phosphorylated on Proline-dependent SP and TP sites when it becomes active at mitosis and the prevalent model is that this phosphorylation/activation of cdc25C would be part of an amplification loop with cdk1/cyclin B1.	neotetrazolium	59-61	cell division cycle 25C	Homo sapiens	6-12
21336108-13	2011	The serum levels of both cystatin C and creatinine were significantly higher in the control group than in the TP group on postoperative day 2.	neotetrazolium	110-112	cystatin C	Homo sapiens	25-35
21894968-3	2011	The resulting complexes TEA[Tp*MoX(S(2)BMOQO)] [1, X = S; 3, X = O; TEA = tetraethylammonium; Tp* = hydrotris(3,5-dimethylpyrazolyl)borate] undergo a dehydration-driven intramolecular cyclization within quinoxalyldithiolene, forming Tp*MoX(pyrrolo-S(2)BMOQO) (2, X = S; 4, X = O).	neotetrazolium	28-30	monooxygenase DBH like 1	Homo sapiens	31-34
21213358-8	2011	TP (5-100 nM) concentration-dependently inhibited the NFkappaB transcriptional activity induced by TNF-alpha, lipopolysaccharide and phorbol 12-myristate 13-acetate in HSC-T6 cells.	neotetrazolium	0-2	tumor necrosis factor	Rattus norvegicus	99-108
21282454-9	2011	d4T-TP levels were independently associated with the TS genotype (low versus high expression; odds ratio [OR] = 86.22; 95% confidence interval [CI] = 8.48 to nonestimable; P = 0.0023).	neotetrazolium	4-6	thymidylate synthetase	Homo sapiens	53-55
21282454-11	2011	Our preliminary data show that polymorphisms in the thymidylate synthase gene are strongly associated with d4T-TP intracellular levels and with development of HALS.	neotetrazolium	111-113	thymidylate synthetase	Homo sapiens	52-72
21251196-11	2011	Furthermore, thrombin-induced release of S1P was attenuated in platelets from TP-deficient mice.	neotetrazolium	78-80	coagulation factor II	Mus musculus	13-21
21251196-11	2011	Furthermore, thrombin-induced release of S1P was attenuated in platelets from TP-deficient mice.	neotetrazolium	78-80	sphingosine-1-phosphate receptor 1	Mus musculus	41-44
21330834-11	2011	In the NACT + RS group, NACT with TP improves the long-term DFS and OS of patients compared with patients who had PVB chemotherapy regimen.	neotetrazolium	34-36	solute carrier family 13 member 5	Homo sapiens	7-11
21330834-11	2011	In the NACT + RS group, NACT with TP improves the long-term DFS and OS of patients compared with patients who had PVB chemotherapy regimen.	neotetrazolium	34-36	solute carrier family 13 member 5	Homo sapiens	24-28
20668692-2	2010	Human cdc25C is phosphorylated on Proline-dependent SP and TP sites when it becomes active at mitosis and the prevalent model is that this phosphorylation/activation of cdc25C would be part of an amplification loop with cdk1/cyclin B1.	neotetrazolium	59-61	cell division cycle 25C	Homo sapiens	169-175
19853959-5	2010	I-BOP, an agonist of TP, stimulated the expression of VEGF in this cell line as well as in another human lung cancer H157 cells in a time and dose dependent manner.	neotetrazolium	21-23	vascular endothelial growth factor A	Homo sapiens	54-58
20050605-2	2010	The bis(tetrahydrofuran) adduct, Tp*UI(2)(THF)(2) (1) (Tp* = hydrotris(3,5-dimethylpyrazolyl)borate), was synthesized by addition of sodium hydrotris(3,5-dimethylpyrazolyl)borate (NaTp*) to an equivalent of UI(3)(THF)(4).	neotetrazolium	33-35	N-acetyltransferase pseudogene	Homo sapiens	180-185
19488439-0	2009	Reactions of Tp(NH[double bond, length as m-dash]CPh(2))(PPh(3))Ru-Cl with HC[triple bond, length as m-dash]CPh in the presence of H(2)O: insertion/hydration products.	neotetrazolium	13-15	caveolin 1	Homo sapiens	57-63
19801655-3	2009	Mass spectrometry analyses revealed that Rad53 is phosphorylated at multiple SQ/TQ and at SP/TP residues, which are typical consensus sites for phosphatidylinositol 3-kinase-related kinases and CDKs, respectively.	neotetrazolium	93-95	serine/threonine/tyrosine protein kinase RAD53	Saccharomyces cerevisiae S288C	41-46
19801655-3	2009	Mass spectrometry analyses revealed that Rad53 is phosphorylated at multiple SQ/TQ and at SP/TP residues, which are typical consensus sites for phosphatidylinositol 3-kinase-related kinases and CDKs, respectively.	neotetrazolium	93-95	cyclin-dependent serine/threonine-protein kinase CDC28	Saccharomyces cerevisiae S288C	194-198
19403525-4	2009	TP-induced suppression of both eNOS and Akt phosphorylation was accompanied by up-regulation of PTEN (phosphatase and tension homolog deleted on chromosome 10), Ser(380)/Thr(382/383) PTEN phosphorylation, and PTEN lipid phosphatase activity.	neotetrazolium	0-2	nitric oxide synthase 3, endothelial cell	Mus musculus	31-35
19403525-4	2009	TP-induced suppression of both eNOS and Akt phosphorylation was accompanied by up-regulation of PTEN (phosphatase and tension homolog deleted on chromosome 10), Ser(380)/Thr(382/383) PTEN phosphorylation, and PTEN lipid phosphatase activity.	neotetrazolium	0-2	thymoma viral proto-oncogene 1	Mus musculus	40-43
19403525-4	2009	TP-induced suppression of both eNOS and Akt phosphorylation was accompanied by up-regulation of PTEN (phosphatase and tension homolog deleted on chromosome 10), Ser(380)/Thr(382/383) PTEN phosphorylation, and PTEN lipid phosphatase activity.	neotetrazolium	0-2	phosphatase and tensin homolog	Mus musculus	96-100
19403525-4	2009	TP-induced suppression of both eNOS and Akt phosphorylation was accompanied by up-regulation of PTEN (phosphatase and tension homolog deleted on chromosome 10), Ser(380)/Thr(382/383) PTEN phosphorylation, and PTEN lipid phosphatase activity.	neotetrazolium	0-2	phosphatase and tensin homolog	Mus musculus	183-187
19403525-4	2009	TP-induced suppression of both eNOS and Akt phosphorylation was accompanied by up-regulation of PTEN (phosphatase and tension homolog deleted on chromosome 10), Ser(380)/Thr(382/383) PTEN phosphorylation, and PTEN lipid phosphatase activity.	neotetrazolium	0-2	phosphatase and tensin homolog	Mus musculus	183-187
19464661-7	2009	Furthermore, TP-mediated phosphoinositide hydrolysis, phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and interleukin-6 production were reduced by the expression of KIAA1005/TPIP.	neotetrazolium	13-15	mitogen-activated protein kinase 3	Homo sapiens	73-120
19464661-7	2009	Furthermore, TP-mediated phosphoinositide hydrolysis, phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and interleukin-6 production were reduced by the expression of KIAA1005/TPIP.	neotetrazolium	13-15	interleukin 6	Homo sapiens	125-138
19464661-7	2009	Furthermore, TP-mediated phosphoinositide hydrolysis, phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and interleukin-6 production were reduced by the expression of KIAA1005/TPIP.	neotetrazolium	13-15	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	Homo sapiens	193-197
19100618-4	2009	At very low concentration, TPS-LZM could significantly reverse the disease progression in renal ischemia-reperfusion (I/R) injury animal models, while the mixture of free TP and LZM was ineffective.	neotetrazolium	27-29	lysozyme	Homo sapiens	31-34
19619443-13	2009	In concurrent chemoradiotherapy, the application rate of granulocyte colony stimulating factor (G-CSF) was significantly higher in TP group than in DDP group (100% vs. 72.0%, p<0.05).	neotetrazolium	131-133	colony stimulating factor 3	Homo sapiens	57-94
19619443-13	2009	In concurrent chemoradiotherapy, the application rate of granulocyte colony stimulating factor (G-CSF) was significantly higher in TP group than in DDP group (100% vs. 72.0%, p<0.05).	neotetrazolium	131-133	colony stimulating factor 3	Homo sapiens	96-101
18702501-2	2008	We demonstrate that n-propanethiol successfully undergoes catalytic alkyne hydrothiolation with both aryl and aliphatic alkynes using Tp*Rh(PPh3)2 as the catalyst.	neotetrazolium	134-137	caveolin 1	Homo sapiens	140-144
18358513-1	2008	The photocatalytic efficiency of two 2,4,6-triphenylpyrylium (TP(+)) based photocatalysts (supported on silica or incorporated inside zeolite Beta, 3wt%) for the degradation of 2,4-dichlorophenol (DCP) in aqueous media has been compared with TiO(2) (Degussa P-25).	neotetrazolium	62-64	tubulin polymerization promoting protein	Homo sapiens	258-262
18723487-11	2008	dFdU is taken up into cells with high affinity by hCNT1 and phosphorylated to its dFdU-TP metabolite.	neotetrazolium	87-89	solute carrier family 28 member 1	Homo sapiens	50-55
18688399-4	2008	For [Rh(eta-cod){B(pz)4}], [Rh(eta-dmbd)Tp"] (dmbd = 2,3-dimethylbuta-1,3-diene) and [Rh(eta-cod)Tp(Ph)] {Tp(Ph) = hydrotris(3-phenylpyrazolyl)borate} the fluxional process is slowed at low temperatures so that inequivalent pyrazolyl rings are observed.	neotetrazolium	40-42	endothelin receptor type A	Homo sapiens	31-34
18688399-4	2008	For [Rh(eta-cod){B(pz)4}], [Rh(eta-dmbd)Tp"] (dmbd = 2,3-dimethylbuta-1,3-diene) and [Rh(eta-cod)Tp(Ph)] {Tp(Ph) = hydrotris(3-phenylpyrazolyl)borate} the fluxional process is slowed at low temperatures so that inequivalent pyrazolyl rings are observed.	neotetrazolium	40-42	endothelin receptor type A	Homo sapiens	31-34
18590695-7	2008	The distances between the protons of H11 and H18, H11 and H19, H15 and H18, and H15 and H19 in U46619 were shorter following their binding to the TP in solution, down to within 5A, which were different than that of the U46619 bound to PGIS and U44069 (another PGH(2) mimic) bound to TXAS.	neotetrazolium	146-148	prostaglandin I2 synthase	Homo sapiens	235-239
18590695-7	2008	The distances between the protons of H11 and H18, H11 and H19, H15 and H18, and H15 and H19 in U46619 were shorter following their binding to the TP in solution, down to within 5A, which were different than that of the U46619 bound to PGIS and U44069 (another PGH(2) mimic) bound to TXAS.	neotetrazolium	146-148	thromboxane A synthase 1	Homo sapiens	283-287
18688399-9	2008	Of the complexes with the more sterically hindered Tp(Ph) ligand, only [Rh(eta-nbd)Tp(Ph)] shows any degree of reversible oxidation.	neotetrazolium	82-85	endothelin receptor type A	Homo sapiens	75-78
17765313-2	2007	The new models are distinctive for the inclusion of pterin-substituted dithiolene chelates and have the formulation Tp(*)MoX(pterin-R-dithiolene) (Tp(*)=tris(3,5,-dimethylpyrazolyl)borate), X=O, S, R=aryl.	neotetrazolium	116-118	monooxygenase DBH like 1	Homo sapiens	121-124
18187198-1	2008	The oxygen atom transfer reactivity of Tp( *)MoO(2)(SPh) (1) (where Tp( *)=hydrotris-(3,5-dimethylpyrazol-1-yl)borate) with trimethyl phosphine (PMe(3)) has been investigated.	neotetrazolium	39-41	surfactant associated 3	Homo sapiens	52-55
17765313-2	2007	The new models are distinctive for the inclusion of pterin-substituted dithiolene chelates and have the formulation Tp(*)MoX(pterin-R-dithiolene) (Tp(*)=tris(3,5,-dimethylpyrazolyl)borate), X=O, S, R=aryl.	neotetrazolium	147-149	monooxygenase DBH like 1	Homo sapiens	121-124
17499743-6	2007	In addition, TP-mediated phosphoinositide hydrolysis was clearly observed in TP alpha-, but not TP beta-expressing cells.	neotetrazolium	13-15	plasminogen activator, tissue type	Homo sapiens	77-85
17632087-2	2007	I-BOP, a TP agonist, induced a time- and dose-dependent expression of COX-2 in A549-TPalpha cells.	neotetrazolium	9-11	BOP	Homo sapiens	2-5
17632087-2	2007	I-BOP, a TP agonist, induced a time- and dose-dependent expression of COX-2 in A549-TPalpha cells.	neotetrazolium	9-11	prostaglandin-endoperoxide synthase 2	Homo sapiens	70-75
17632087-2	2007	I-BOP, a TP agonist, induced a time- and dose-dependent expression of COX-2 in A549-TPalpha cells.	neotetrazolium	9-11	plasminogen activator, tissue type	Homo sapiens	84-91
17160175-3	2007	The dependence of both oxidation potential and nu(CO) for [MX(CO)(eta-RC[triple bond, length as m-dash]CR)Tp"] shows an inverse halide order which is consistent with an ionic component to the M-X bond; the small size of fluorine and its closeness to the metal centre leads to the highest energy HOMO and the lowest oxidation potential.	neotetrazolium	106-108	endothelin receptor type A	Homo sapiens	66-69
17241518-9	2007	TP induced a robust activation of Akt and the inactivation of GSK3beta via PI3-K.	neotetrazolium	0-2	AKT serine/threonine kinase 1	Rattus norvegicus	34-37
17241518-9	2007	TP induced a robust activation of Akt and the inactivation of GSK3beta via PI3-K.	neotetrazolium	0-2	glycogen synthase kinase 3 beta	Rattus norvegicus	62-70
16688324-1	2006	The synthesis and characterisation of the cyclobutyl complex Tp(Me2)NbCl(c-C4H7)(MeC[triple bond]CMe) completes the family of cycloalkyl complexes Tp(Me2)NbCl(c-C(n)H(2n-1)), n = 3-6.	neotetrazolium	61-63	malic enzyme 2	Homo sapiens	64-67
16782917-7	2006	Improved clinical outcomes with TPC were most evident in HER-2 3+ patients, with an ORR of 57% (95% CI, 45% to 70%) v 36% (95% CI, 25% to 48%; P = .03) and median PFS of 13.8 v 7.6 months (P = .005) for TPC and TP, respectively (HR, 0.55; 95% CI, 0.46 to 0.64).	neotetrazolium	32-34	erb-b2 receptor tyrosine kinase 2	Homo sapiens	57-62
16688324-1	2006	The synthesis and characterisation of the cyclobutyl complex Tp(Me2)NbCl(c-C4H7)(MeC[triple bond]CMe) completes the family of cycloalkyl complexes Tp(Me2)NbCl(c-C(n)H(2n-1)), n = 3-6.	neotetrazolium	61-63	C-C motif chemokine ligand 28	Homo sapiens	81-84
16688324-1	2006	The synthesis and characterisation of the cyclobutyl complex Tp(Me2)NbCl(c-C4H7)(MeC[triple bond]CMe) completes the family of cycloalkyl complexes Tp(Me2)NbCl(c-C(n)H(2n-1)), n = 3-6.	neotetrazolium	61-63	malic enzyme 2	Homo sapiens	150-153
16351085-3	2005	We report herein that Tp*Rh(PPh3)2 (Tp* = hydrotris(3,5-dimethylpyrazolyl)borate) is a highly active catalyst for alkyne hydrothiolation with alkyl and aryl thiols.	neotetrazolium	22-24	caveolin 1	Homo sapiens	28-32
16567086-7	2006	Our findings revealed a decrease in prostate growth in the NMU/TP/GLA-fed group as determined by weight, tissue size, DNA content and prostate-specific antigen (tumor marker of prostate cancer).	neotetrazolium	63-65	neuromedin U	Homo sapiens	59-62
16567086-7	2006	Our findings revealed a decrease in prostate growth in the NMU/TP/GLA-fed group as determined by weight, tissue size, DNA content and prostate-specific antigen (tumor marker of prostate cancer).	neotetrazolium	63-65	kallikrein related peptidase 3	Homo sapiens	134-192
16567086-8	2006	Comparison between the two groups showed a significant increase in 5S-hydroxyeicosatetraenoic acid and prostaglandin E(2) in the NMU/TP group.	neotetrazolium	133-135	neuromedin U	Homo sapiens	129-132
16441102-1	2006	X-ray crystallography and resonance Raman (rR) spectroscopy have been used to further characterize (Tp*)MoO(qdt) (Tp* is hydrotris(3,5-dimethyl-1-pyrazolyl)borate and qdt is 2,3-quinoxalinedithiolene), which represents an important benchmark oxomolybdenum mono-dithiolene model system relevant to various pyranopterin Mo enzyme active sites, including sulfite oxidase.	neotetrazolium	100-102	sulfite oxidase	Homo sapiens	352-367
16351085-3	2005	We report herein that Tp*Rh(PPh3)2 (Tp* = hydrotris(3,5-dimethylpyrazolyl)borate) is a highly active catalyst for alkyne hydrothiolation with alkyl and aryl thiols.	neotetrazolium	36-38	caveolin 1	Homo sapiens	28-32
16234937-2	2005	As well, a novel "organoscorpionate" complex, [W{S2C2(CO2Me)2}{SC2(CO2Me)2-Tp*}], has been isolated from the reactions of NEt4[Tp*WS3] with excess DMAC.	neotetrazolium	75-77	tetraspanin 5	Homo sapiens	122-126
16322691-7	2005	However, TP-DC vaccination in vivo increased the IFN-gamma production from splenocytes higher than that of UP-DC (TP- vs. UP-DC; 41029+/-1523 vs. 4752+/-590 pg/ml, respectively).	neotetrazolium	9-11	interferon gamma	Mus musculus	49-58
15759894-1	2004	Under the condition of keeping the influent COD: TN: TP = 100:5:1, submerged MBR has an excellent treatment performance for COD and NH4+ -N, and the removals for COD and NH4+ -N are both beyond 90% under steady state, in addition, MBR has a strong adaptation ability for shock organics loading rate.	neotetrazolium	53-55	translocator protein	Homo sapiens	77-80
15884057-3	2005	One G protein receptor that can couple to Galpha(12/13) subunits is the receptor for thromboxane A(2 )(TXA(2)), thromboxane-prostanoid (called TP), which is highly expressed in immature thymocytes.	neotetrazolium	143-145	thromboxane A2 receptor	Mus musculus	112-134
15786505-1	2005	Intermediates in the oxygen atom transfer from Mo(VI) to P(III), [Tp(iPr)MoOX(OPR3)] (Tp(iPr) = hydrotris(3-isopropylpyrazol-1-yl)borate; X = Cl-, phenolates, thiolates), have been isolated from the reactions of [Tp(iPr)MoO2X] with phosphines (PEt3, PMePh2, PPh3).	neotetrazolium	66-68	protein phosphatase 4 catalytic subunit	Homo sapiens	258-262
15786505-1	2005	Intermediates in the oxygen atom transfer from Mo(VI) to P(III), [Tp(iPr)MoOX(OPR3)] (Tp(iPr) = hydrotris(3-isopropylpyrazol-1-yl)borate; X = Cl-, phenolates, thiolates), have been isolated from the reactions of [Tp(iPr)MoO2X] with phosphines (PEt3, PMePh2, PPh3).	neotetrazolium	86-88	protein phosphatase 4 catalytic subunit	Homo sapiens	258-262
15759894-1	2004	Under the condition of keeping the influent COD: TN: TP = 100:5:1, submerged MBR has an excellent treatment performance for COD and NH4+ -N, and the removals for COD and NH4+ -N are both beyond 90% under steady state, in addition, MBR has a strong adaptation ability for shock organics loading rate.	neotetrazolium	53-55	translocator protein	Homo sapiens	231-234
12844309-1	2003	The electronic and magnetic properties of a series of mixed-sandwich complexes MCp(R)Tp (Cp(R) = Cp or Cp; Tp = hydrotris(pyrazolyl)borate; M = V, Cr, Fe, Co or Ni) have been studied and compared to their homoleptic analogues, MCp(R)(2) and MTp(2).	neotetrazolium	85-87	CD46 molecule	Homo sapiens	79-82
15493934-1	2004	The arene ligand in the complex TpRe(CO)(MeIm)(eta2-benzene) (Tp = hydridotris(pyrazolyl)borate; MeIm = N-methylimidazole) undergoes tandem electrophile/nucleophile 1,4-addition reactions.	neotetrazolium	32-34	DNA polymerase iota	Homo sapiens	47-51
15500686-12	2004	Stromal immunostaining for COX-1 as well as COX-2 was increased in the TP and PP groups as compared to the NP, and GE displayed an intensely increased COX-2 immunostaining at term and postpartum.	neotetrazolium	71-73	mitochondrially encoded cytochrome c oxidase I	Homo sapiens	27-32
15500686-12	2004	Stromal immunostaining for COX-1 as well as COX-2 was increased in the TP and PP groups as compared to the NP, and GE displayed an intensely increased COX-2 immunostaining at term and postpartum.	neotetrazolium	71-73	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	44-49
14557367-6	2003	Furthermore, in indomethacin-treated wild-type VSMCs, U-46619, a TP agonist, inhibited cytokine-induced iNOS expression and NO production in a concentration-dependent manner, effects absent from TP-/- VSMCs.	neotetrazolium	65-67	nitric oxide synthase 2, inducible	Mus musculus	104-108
12586835-4	2003	In mitotic HeLa cells, when the activity of Cdc2 is high, S6K1 is phosphorylated at multiple Ser/Thr, Pro (S/TP) sites, including Ser(371), Ser(411), Thr(421), and Ser(424).	neotetrazolium	109-111	cyclin dependent kinase 1	Homo sapiens	44-48
12586835-4	2003	In mitotic HeLa cells, when the activity of Cdc2 is high, S6K1 is phosphorylated at multiple Ser/Thr, Pro (S/TP) sites, including Ser(371), Ser(411), Thr(421), and Ser(424).	neotetrazolium	109-111	ribosomal protein S6 kinase B1	Homo sapiens	58-62
12639658-6	2003	The mean total dose and duration of morphine administration were higher in the TP-LRP group, but the difference was not statistically significant (6.0 mg versus 12.8 mg and 0.5 day versus 0.9 day, respectively).	neotetrazolium	79-81	LDL receptor related protein 1	Homo sapiens	82-85
11710394-11	2001	On the contrary, myocardial NO generation and iNOS expression were significantly reduced after repeated inhalation of hypobaric oxygen at 5500 m. NO metabolism regained to normal after repeated administration of TP.	neotetrazolium	212-214	nitric oxide synthase 2, inducible	Mus musculus	46-50
12487134-1	2002	The (alpha =3, beta =2) member of the (A3ABO6) (A3B3O9) homologous series has been stabilised in the Sr-Rh-O system for a [Sr10(Sr0.5Rh1.5)TP(Rh6)Oh]O24 composition.	neotetrazolium	139-141	potassium calcium-activated channel subfamily M regulatory beta subunit 2	Homo sapiens	5-22
12093179-5	2002	Immunoprecipitation of each deletion mutant protein by M2 beads showed that binding of Hsp60 to human HBV Pol requires two minimal sites on human HBV Pol: amino acids 1 to 199 (TP) and amino acids 680 to 842 (RH).	neotetrazolium	177-179	heat shock protein family D (Hsp60) member 1	Homo sapiens	87-92
12565868-6	2003	TP inhibited a number of steps in the cisplatin-induced apoptotic pathway, activation of caspases 3 and 9 and mitochondrial cytochrome c release.	neotetrazolium	0-2	caspase 3	Homo sapiens	89-105
12565868-6	2003	TP inhibited a number of steps in the cisplatin-induced apoptotic pathway, activation of caspases 3 and 9 and mitochondrial cytochrome c release.	neotetrazolium	0-2	cytochrome c, somatic	Homo sapiens	124-136
12120080-0	2002	Synthesis of the RuIV amido complex [TpRu(CO)(PPh3)(NHPh)][OTf]2 (Tp = hydridotris(pyrazolyl)borate; OTf = trifluoromethanesulfonate) and deprotonation to form an octahedral and d4 imido complex: computational study of RuIV-imido bonding.	neotetrazolium	37-39	caveolin 1	Homo sapiens	46-50
10887296-1	2000	Covalently bound conjugates of alpha-fetoprotein (AFP) and epidermal growth factor (EGF) with photoheme (PH), 3-desvinyl-3-formylchlorine p6 (Chl p6), chlorine e6 (Chl e6), aluminum disulfochloride phthalocyanine (PC(Al)), and cobalt octa-4,5-carboxyphthalocyanine (teraphthal, TP(Co)) were synthesized.	neotetrazolium	278-280	alpha fetoprotein	Homo sapiens	31-48
10887296-1	2000	Covalently bound conjugates of alpha-fetoprotein (AFP) and epidermal growth factor (EGF) with photoheme (PH), 3-desvinyl-3-formylchlorine p6 (Chl p6), chlorine e6 (Chl e6), aluminum disulfochloride phthalocyanine (PC(Al)), and cobalt octa-4,5-carboxyphthalocyanine (teraphthal, TP(Co)) were synthesized.	neotetrazolium	278-280	alpha fetoprotein	Homo sapiens	50-53
10887296-1	2000	Covalently bound conjugates of alpha-fetoprotein (AFP) and epidermal growth factor (EGF) with photoheme (PH), 3-desvinyl-3-formylchlorine p6 (Chl p6), chlorine e6 (Chl e6), aluminum disulfochloride phthalocyanine (PC(Al)), and cobalt octa-4,5-carboxyphthalocyanine (teraphthal, TP(Co)) were synthesized.	neotetrazolium	278-280	epidermal growth factor	Homo sapiens	59-82
10887296-1	2000	Covalently bound conjugates of alpha-fetoprotein (AFP) and epidermal growth factor (EGF) with photoheme (PH), 3-desvinyl-3-formylchlorine p6 (Chl p6), chlorine e6 (Chl e6), aluminum disulfochloride phthalocyanine (PC(Al)), and cobalt octa-4,5-carboxyphthalocyanine (teraphthal, TP(Co)) were synthesized.	neotetrazolium	278-280	epidermal growth factor	Homo sapiens	84-87
10455234-6	1999	SAC1 encodes a protein which has been previously implicated in the correct function of the actin cytoskeleton, in inositol metabolism, in ATP transport in the endoplasmic reticulum and in Sec14p (PI-TP) function.	neotetrazolium	139-141	phosphatidylinositol-3-phosphatase SAC1	Saccharomyces cerevisiae S288C	0-4
11272552-0	2000	Comparing the isoelectronic complexes [RuTp(CH3CN)3]PF6 (Tp = hydridotris(pyrazolyl)borate) and.	neotetrazolium	41-43	sperm associated antigen 17	Homo sapiens	52-55
10582692-2	1999	Previous studies have shown that the oxygen insensitivity of the histochemical reaction to detect glucose-6-phosphate dehydrogenase activity based on neotetrazolium reduction can be used for discriminating malignant cells from nonmalignant cells.	neotetrazolium	150-164	glucose-6-phosphate dehydrogenase	Homo sapiens	98-131
9313928-5	1997	The DP, IP and TP receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as PGD2, BW245C and BW868C for DP, cicaprost, iloprost and isocabacyclin for IP, and S-145, I-BOP and GR 32191 for TP.	neotetrazolium	15-17	prostaglandin D2 synthase (brain)	Mus musculus	136-140
9799628-7	1998	TP and EB, but not DHTP, masculinized CA1 pyramidal cell field volume and neuronal soma size; CA3 was masculinized in both TP- and DHTP-treated females, while EB was ineffective.	neotetrazolium	0-2	carbonic anhydrase 1	Rattus norvegicus	38-41
9359428-4	1997	Both full activation by Ca2+ ions and stimulation in the presence of PI-TP require an intact PH domain involved in the membrane attachment of PLCdelta1.	neotetrazolium	72-74	phospholipase C delta 1	Homo sapiens	142-151
9485026-7	1998	Inhibitory effects of TP-69 or TP-72 on iNOS formation were not blocked by the glucocorticoid receptor antagonist RU-486, indicating that these triterpenoids do not act through the glucocorticoid receptor, nor does TP-72 act as an iNOS or COX-2 enzyme inhibitor when added to RAW cells in which synthesis of these two enzymes in response to LPS has already been induced.	neotetrazolium	22-24	nitric oxide synthase 2, inducible	Mus musculus	40-44
9485026-7	1998	Inhibitory effects of TP-69 or TP-72 on iNOS formation were not blocked by the glucocorticoid receptor antagonist RU-486, indicating that these triterpenoids do not act through the glucocorticoid receptor, nor does TP-72 act as an iNOS or COX-2 enzyme inhibitor when added to RAW cells in which synthesis of these two enzymes in response to LPS has already been induced.	neotetrazolium	31-33	nitric oxide synthase 2, inducible	Mus musculus	40-44
7583124-2	1995	Here, we test the hypothesis that the principal role of PI-TP is to couple sites of lipid hydrolysis to sites of synthesis, and so to replenish depleted substrate for PLC-beta.	neotetrazolium	59-61	heparan sulfate proteoglycan 2	Homo sapiens	167-170
9306960-1	1997	The effects of oxygen on the quantitative histochemical assay to detect glucose-6-phosphate dehydrogenase (G6PDH) activity based on neotetrazolium reduction were studied in the different stages of carcinogenesis in the colon.	neotetrazolium	132-146	glucose-6-phosphate dehydrogenase	Homo sapiens	72-105
9306960-1	1997	The effects of oxygen on the quantitative histochemical assay to detect glucose-6-phosphate dehydrogenase (G6PDH) activity based on neotetrazolium reduction were studied in the different stages of carcinogenesis in the colon.	neotetrazolium	132-146	glucose-6-phosphate dehydrogenase	Homo sapiens	107-112
7583124-10	1995	CONCLUSIONS: The predicted function of PI-TP in inositol lipid signalling is the provision of substrate for PLC-beta from intracellular sites where PI is synthesized.	neotetrazolium	42-44	heparan sulfate proteoglycan 2	Homo sapiens	108-111
1934006-1	1991	Immunohistochemically detectable erythropoietin-like substance(Epo) in granular convoluted tubule(GCT) cells of submandibular glands (SMG"s) was examined in mice in which hemolytic anemia had been induced by phenylhydrazine (ph), and in mice subjected to hypoxia, nephrectomy, or testosterone (TP) injections.	neotetrazolium	294-296	erythropoietin	Mus musculus	63-66
2379174-1	1990	It was found to be possible to distinguish malignant cells from normal cells by using an oxygen-sensitive tetrazolium salt (neotetrazolium) for the histochemical demonstration of glucose-6-phosphate dehydrogenase activity in cryostat sections of human colon.	neotetrazolium	124-138	glucose-6-phosphate dehydrogenase	Homo sapiens	179-212
17944460-10	2007	X-ray diffraction studies of K[Tp"(CO)(Me3CNC)Mo(eta2-C2S2)] (K-3c), 4b, 6a, 6b, and 7 are included.	neotetrazolium	31-34	DNA polymerase iota	Homo sapiens	49-53
7930518-1	1994	We used the oxygen sensitivity of the histochemical reaction to detect glucose-6-phosphate dehydrogenase (G6PDH) activity based on neotetrazolium (NT) reduction to discriminate cancer cells from normal cells.	neotetrazolium	131-145	glucose-6-phosphate dehydrogenase	Rattus norvegicus	71-104
7930518-1	1994	We used the oxygen sensitivity of the histochemical reaction to detect glucose-6-phosphate dehydrogenase (G6PDH) activity based on neotetrazolium (NT) reduction to discriminate cancer cells from normal cells.	neotetrazolium	131-145	glucose-6-phosphate dehydrogenase	Rattus norvegicus	106-111
7930518-1	1994	We used the oxygen sensitivity of the histochemical reaction to detect glucose-6-phosphate dehydrogenase (G6PDH) activity based on neotetrazolium (NT) reduction to discriminate cancer cells from normal cells.	neotetrazolium	147-149	glucose-6-phosphate dehydrogenase	Rattus norvegicus	71-104
7930518-1	1994	We used the oxygen sensitivity of the histochemical reaction to detect glucose-6-phosphate dehydrogenase (G6PDH) activity based on neotetrazolium (NT) reduction to discriminate cancer cells from normal cells.	neotetrazolium	147-149	glucose-6-phosphate dehydrogenase	Rattus norvegicus	106-111
7930518-10	1994	These experiments clearly indicate that the oxygen sensitivity phenomenon is not solely an effect of competition for reducing equivalents between NT and oxygen via SOD, because NADPH generated by G6PDH and NADH generated by LDH have a similar redox potential.	neotetrazolium	146-148	glucose-6-phosphate dehydrogenase	Rattus norvegicus	196-201
8223486-5	1993	These collective data demonstrate that while the in vitro PI-TP activity of SEC14p clearly reflects some functional in vivo property of SEC14p, the PI-TP activity is not the sole essential activity of SEC14p.	neotetrazolium	61-63	phosphatidylinositol/phosphatidylcholine transfer protein SEC14	Saccharomyces cerevisiae S288C	76-82